Platinum pharmacokinetics in sulphur-crested cockatoos (Cacatua galerita) following single-dose cisplatin infusion

Australian Veterinary Journal

Volumn 78, Issue 6, 2000, Pages 406-411

  Filippich, L J ^a   Bucher, A M ^a   Charles, B G ^a  

^a UNIVERSITY OF QUEENSLAND   (Australia)

Author keywords

Cockatoo; Pharmacokinetics; Platinum

Indexed keywords

ANIMALIA; AVES; CACATUA GALERITA; CACATUIDAE; CANIS FAMILIARIS; GALERITA; RODENTIA;

ANTINEOPLASTIC AGENT; CISPLATIN;

ANIMAL; ANIMAL DISEASE; ARTICLE; BLOOD; FEMALE; INTRAVENOUS DRUG ADMINISTRATION; MALE; METABOLISM; PSITTACINE; URINE;

ANIMALS; ANTINEOPLASTIC AGENTS; CISPLATIN; FEMALE; INFUSIONS, INTRAVENOUS; MALE; PSITTACIFORMES;

EID: 0034203820     PISSN: 00050423     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1751-0813.2000.tb11829.x     Document Type: Article

References (27)

1. Page R, Matus RE, Leifer CE, Loar A. Cisplatin, a new antineoplastic drug in veterinary medicine. J Am Vet Med Assoc 1985;186:288-290
2. Johnsson A, Hoglund P, Grubb A, Cavallin-Stahl E. Cisplatin pharmacokinetics and pharmacodynamics in patients with squamous-cell carcinoma of the head/neck or esophagus. Cancer Chemother Pharmacol 1996;39:25-33.
3. Shapiro W. Cisplatin chemotherapy. In: Kirk RW, Bonagura JD, editors. Current veterinary therapy X Small Animal Practice. Saunders, Philadelphia, 1989:497-502.
4. Kraegel SA, Madewell BR, Simonson E, Gregory CR. Osteogenic sarcoma and cisplatin chemotherapy in dogs: 16 cases (1986-1989). J Am Vet Med Assoc 1991;199:1057-1059.
5. Berg J. Canine osteosarcoma. Vet Clin North Am Small Anim Pract 1996;26:111-121.
6. Blackmore DK. The clinical approach to tumours in cage birds-I. The pathology and incidence of neoplasia in cage birds. J Small Anim Pract 1966;7:217-223.
7. Petrak ML, Gilmore CE. Neoplasms. In: Petrak ML, editor. Diseases of caged and aviary birds. 2nd ed. Lea & Febiger, Philadelphia, 1982:606-637.
8. Reece RL. Observations on naturally occurring neoplasms in birds in the state of Victoria, Australia. Avian Pathol 1992;21:3-32.
9. Ramsay EC, Bos JH, McFadden C. Use of intratumoral cisplatin and orthovoltage radiotherapy in treatment of a fibrosarcoma in a macaw. J Assoc Avian Vet 1993;7:87-90.
10. Siddik ZH, Newell DR, Boxall FE, Harrap KR. The comparative pharmacokinetics of carboplatin and cisplatin in mice and rats. Biochem Pharmacol 1987;36:1925-1932.
11. King FG, Dedrick RL. Physiological parameters for cis-dichlorodiammineplatinum (II) (DDP) in the mouse. J Pharmacokin Biopharm 1992;20:95-99.
12. Litterst CL, Gram TE, Dedrick RL, Leroy AF, Guarino AM. Distribution and disposition of platinum following intravenous administration of cis-diamminedichloroplatinurn(II) (NSC 119875) to dogs. Cancer Res 1976;36:2340-2344.
13. Hardie EM, Page RL, Williams PL, Fischer WD. Effect of time of cisplatin administration on its toxicity and pharmacokinetics in dogs. Am J Vet Res 1991;52:1821-1825.
14. Lau M, Filippich LJ. Humidified anaesthetic gas. In: Proceedings of the Association of Avian Veterinarians-Australian Committee 1996:19-26.
15. Taylor A, Branch S, Crews HM et al. Atomic spectrometry - clinical and biological materials, foods and beverages. J Anal At Spectrom 1993;8:79R-113R.
16. Rowland M, Tozer TN. Clinical Pharmacokinetics. Concepts and applications. 3rd edn. Lea & Febiger, Philadelphia, 1995:438-439.
17. Miller SE, House DA. The hydrolysis products of cis-dichlorodiammineplatinum (II) 3. Hydrolysis kinetics at physiological pH. Inorg Chim Acta 1990;173:53-60.
18. Heudi O, Cailleux A, Allain P. Kinetic studies of the reactivity between cisplatin and its monoaquo species with L-methionine. J Inorg Biochem 1998;71:61-69.
19. Patton TF, Repta AJ, Sternson LA, Belt RJ. Pharmacokinetics of intact cisplatin in plasma. Infusion versus bolus dosing. Int J Pharm 1982;10:77-85.
20. El-Khateeb M, Appleton TG, Charles BG, Gahan LR. Development of HPLC conditions for valid determination of hydrolysis products of cisplatin. J Pharm Sci 1999;88:319-326.
21. Gormley PE, Bull JM, LeRoy AF, Cysyk R. Kinetics of cis-dichlorodiammineplatinum. Clin Pharmacol Ther 1979;25:351-357.
22. Himmelstein KJ, Patton TF, Belt RJ et al. Clinical kinetics of intact cisplatin and some related species. Clin Pharmacol Ther 1981;29:658-664.
23. Vermorken JB, van der Vijgh WJF, Klein I et al. Pharmacokinetics of free and total platinum species after rapid and prolonged infusions of cisplatin. Clin Pharmacol Ther 1986;39:136-144.
24. Rosenberg B. Fundamental studies with cisplatin. Cancer 1985;55:2303-2316.
25. Reece PA, Stafford I, Davy M, Freeman S. Disposition of unchanged cisplatin in patients with ovarian cancer. Clin Pharmacol Ther 1987;42:320-325.
26. Charles BG, Filippich LJ, Bucher A. Pharmacokinetic disposition of platinum following cisplatin administration to parrots. In: Proceedings of the 8th International symposium on Platinum and other metal coordination compounds in cancer chemotherapy 1999;2:2.
27. Gibbons G, Pokras M, Sedgwick C. Allometric scaling in veterinary medicine. Aust Vet Pract 1988;18:160-164.